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Dinuclear CuII and MnII bis-phenanthroline octanedioate complexes
exhibit rapid, unprecedented nano and picomolar in vitro cytotoxicity
against colorectal cancer lines and are less toxic than cisplatin when
examined in vivo. The complexes are potent generators of cellular
reactive oxygen species, avid DNA binders and induce O2 dependent
cleavage of DNA. The Cu(II) complex was found to have selfcleaving nuclease activity.
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The development of self-cleaving chemical nucleases is regarded
as the paradigm of redox-active metal-based chemotherapeutics.
DNA targeted agents capable of inducing single stranded or
double stranded scission have found clinical application within
cancer chemotherapy.1 Other applications within this class
include; probing of DNA-specific structures, mapping of protein
and DNA interactions, gene regulation and signal transduction.2, 3
Thus, explorations toward the discovery and development of
natural or synthetic chemical nucleases are major topics of
interest. Redox active transition-metal-based chemical nucleases
are particularly important due to their catalytic potential to
support the one-electron oxidation/reduction reactions necessary
to drive activation of C-H deoxyribose bonds.
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Figure 1. Molecular strucutres of phen, odaH2 and the phthalates
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In the presence of Cu2+, the oxidative formation of π
radical cations within marine-based products tambjamine E,4
prodigiosin5 and pyrimol,6 have recently been shown to mediate
self-cleaving DNA damage, i.e. scission which does not require
the presence of added oxidant or reductant. These Cu2+
compounds have also demonstrated significant in vitro
chemotherapeutic potential against leukaemia and ovarian cancer
cells, some of which had cisplatin resistance.5, 6
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The discovery of the first synthetic chemical nuclease,
[Cu(phen)2]2+ (phen = 1,10-phenanthroline, Figure 1), has
sparked intensive effort toward the development of new bis-phen
agents capable of enhanced DNA cleaving compared to the parent
complex.7 The DNA cleaving limitations of [Cu(phen)2]2+ include
(i) a high dissociation constant of the second coordinated
phenanthroline ligand8 and (ii) the need for exogenous reductant
to generate the active species [Cu(phen)2]+. The dissociation
problem (i) was solved by Meunier, Pitie et al through the advent
of clip-phen, whereby two phenanthroline ligands are connected
at the 2’ or 3’ position by a serinol bridge.9-11 Recently this
laboratory has reported the first self-cleaving bis-phen system,
[Cu(phen)2(phthalate)] (phthalate = o-, m-, p-phthalate, Figure
1), capable of inducing single-stranded DNA scission in the
absence of exogenous reductant or oxidant.12

While [Cu(phen)2(phthalate)] complexes displayed
excellent chemotherapeutic potential against, colon (HT29),
breast (MC-F7) and prostate (DU145) cancer lines, their water
solubility is poor. Of the phthalate group, the cationic, dinuclear
species [Cu2(phen)4(µ 2-p-phthalate)]2+ was the most active DNAbinding, self-cleaving and chemotherapeutic agent. To that end,
in the current study, we have investigated the application of water
soluble Cu2+ and Mn2+ dinuclear, cationic, bis-phen octanedioate
(oda) (Figure 1) systems as nuclease mimetics and their ability to
induce cancer cell death through the redox-generation of reactive
oxygen species (ROS). The possible formation of a π carboxyl
radical within the Cu2+ system, which cleaves DNA by selfactivation, is also discussed.
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The title complexes [Cu2(µ 2-oda)(phen)4](ClO4)2 (1)
(Figure
2),
[Mn2(µ 2-oda)(phen)4(H2O)2(oda)2]2-[Mn2(µ 22+
oda)(phen)4(H2O)2] (2) (Figure 3), were prepared according to
the literature methods by McCann and Devereux et al.13, 14 The
coordination environment about both Cu2+ ions in 1 is
approximately square-pyramidal with both metals being linked
via a bridging oda ligand. In the double salt complex 2, the
environment about each Mn2+ is octahedral with both metals in
the cationic and anionic groups being bridged by oda in a similar
fashion to 1. Whereas the Mn2+ centres of the anionic subunit in 2
each contain a singly bound oda dianion coordinated in the apical
position, the cationic unit contains bound water at these
equivalent positions.
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Figure 2. Molecular strucutre the [Cu2(µ 2-oda)(phen)4]2+ cation in
complex 1
100
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Figure 3. Molecular strucutres of the dimeric cation and anion
subunits in the MnII double salt complex [Mn2(µ 2oda)(phen)4(H2O)2(oda)2]2-[Mn2(µ 2-oda)(phen)4(H2O)2]2+ (2)
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was examined at 20 µM over two hours in the presence of
ascorbate while the Cu2+ system was examined at 20 µM over 20
hr without added reductant. Both complexes did not cleave DNA
in the absence of oxygen but complex 1 was found to induce
some DNA damage in the presence of excess metal chelator
(EDTA).
Figure 4. Relaxation of pUC18 by 1 and 2.† Cleavage was carried out at
37°C then analyzed by agarose gel electrophoresis† (a) 20hr incubation in the
absence of added oxidant or reductant, lane 1: DNA alone; lanes 2-6: 1, 5, 10,
20, 50 µM 1; lanes 7-10: 5, 10, 20, 50 µM 2. (b) 2hr incubation in the presence
of added ascorbate (at twice complex concentration), lane 1: DNA alone; lanes
2-5: 1, 5, 10, 20 µM 1; lanes 6-9: 1, 5, 10, 20 µM 2. (c) 20hr incubation of 20
µM 1 in the absence of added oxidant or reductant, lane 1: + 100 mM
Na2EDTA; lane 2: sat. Ar atmosphere. (d) 2hr incubation of 20 µM 2 with
added ascorbate (at twice complex concentration), lane 1: + 100 mM
Na2EDTA; lane 2: sat. Ar atmosphere.

Redox Activity

DNA Binding Studies
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25

In order to examine the interaction of compounds 1 & 2 with
DNA, competitive ethidium bromide displacement and
fluorescence quenching experiments with calf thymus DNA were
conducted (Table 1).† Complexes 1 & 2 were found to have high
apparent DNA binding constants (Kapp), and low fluorescence
quenching values (Q), indicating that both systems have a high
affinity for binding to DNA.

Figure 5. SOD activity profiles for complexes 1 and 2

Table 1. Apparent DNA binding constants (Kapp) and Q values for 1 and 2.†

30

Assay conditions; C50/Kapp: final volume 2 mL, 1.2 µM EtBr, 1 µM CT-DNAp,
10 mM TES, 0.1 mM Na2EDTA, pH 7.0; Q: final volume 2 mL, 2.0 µM EtBr,
20 µM CT-DNAp, 2 mM NaOAc buffer, 9.3 mM NaCl, 0.1 mM Na2EDTA, pH
5.0
Complex
C50* (µM)
Kapp**
Q‡
22.64
46.89
2.55 x 105
1
28.46
4.20 x 105
43.13
2
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*

C50 = concentration required to reduce fluorescence by 50% (Competitive)
Kapp =
Ke x 1.26/C50 where
Ke
=
9.5 x 106
M(bp)-1
‡
Q = equivalent concentration required to reduce fluorescence by 50% (Quenching)

**
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DNA Cleavage Reactions
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Relaxation of supercoiled (SC) pUC18 DNA (Form I) into open
circular (OC, Form II) and linear (LC, Form III) conformations
was used to quantify the relative cleavage efficiency of 1 & 2.†
To examine for DNA self-cleaving ability, SC DNA was exposed
to both complexes over a concentration range of 1-50 µM for 20
hours in the absence of added H2O2 or reductant (Figure 4(a)).
Complex 1 shows concentration-dependant self-cleaving of SC
(Form I) DNA to OC (Form II) with complete depletion of the
parent SC band (I→II) between 10-20 µM (lane 4 & 5 (a)). In the
presence of added reductant (ascorbate) (Figure 4(b)) both
complexes exhibit enhanced DNA scission during a shorter timeframe (2hr). While both 1 & 2 induced complete relaxation to OC
Form II (lanes 4 & 8 (b)) at 10 µM, the Cu2+ complex was found
to induce efficient double stranded scission (I→III) at a
concentration of 20 µM, characterised by the absence of a band in
lane 5 (b). In order to identify what role molecular O2 and the
metal cations (Cu2+/Mn2+) play within DNA cleavage,
experiments were conducted under anaerobic conditions in an
atmosphere saturated with argon and, separately, in the presence
of 100 mM Na2EDTA (Figure 4 (c) & (d)). The Mn2+ system
2 | Journal Name, [year], [vol], 00–00
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Table 2. SOD concentrations of complexes 1 and 2 equivalent to effect 1U of
Bovine Erythrocyte SOD activity (50% Inhibition) and Catalase mimetic
potential of 1 and 2 examined as a function of H2O2 disproportionation
Complex
Concentration Equivalent
Number of H2O2 molecules
to 1U Bovine SOD (µM)
disproportionated by one molecule
of complex in the first 5 min14
1.300
0
1
0.024
6 x 103
2

Since the catalytic interaction of [Cu(phen)2]2+ and its reduced
form, [Cu(phen)2]+, with the superoxide radical (O2•-) and
hydrogen peroxide (H2O2) are imperitive for cleaving the
phosphodiester backbone in DNA,15-17 we have examined the
interaction of complexes 1 and 2 with both these species.
Superoxide
was
generated
enzymatically
by
the
xanthine/xanthine-oxidase system and quantified photometrically
by the detector nitro-blue-tetrazolium (NBT). Both complexes 1
and 2 show potent SOD (superoxide dismutase) mimetic activity
with the Mn2+ system being an exceptional catalyst (1U SOD =
24.6 nM) (Figure 5 & Table 2). The catalase mimetic activity of
complexes 1 & 2 were examined as a function of oxygen
evolution. After the addition of a 30% v/v solution of H2O2 to 1
& 2 the O2 gas evolved was quantified volumetrically (Table 2).
Only the Mn2+ complex (2) was capable of decomposing H2O2
and its activity can also be described as exceptional in this regard
(6 x 103 H2O2 molecules disproportionated in 5 min). Overall,
both complexes 1 & 2 interacted with superoxide to produce
hydrogen peroxide (I), but, only the Mn2+ complex (2) appears
capable of disproportionates the resulting peroxide (II).
I.
II.

2O2•- + 2H+ → 2H2O2 + O2 (SOD)
(CAT)
2H2O2 → 2H2O + O2

This journal is © The Royal Society of Chemistry [year]

Antitumour Activity

50

Table 3. LD50 (at ± 95% CI) values for complexes 1 and 2, the free ligand
phen and the antitumour agent cisplatin, against colorectal cancer lines HT29,
†
SW480 and SW620 over a period of 24 and 96 hours Alan do we need
5

±SD values here? Also can you include the HaCaT results
here?

phen
1
2
cisplatin

10

15

20

HT29
24 hr
<200
9.610
108.00
166.00

Antitumour Activity LD50 (µM)
SW480
SW640
96 hr
24 hr
96 hr
24 hr
9.240
<200
10.70
160.00
>0.001
11.30
0.220
31.00
0.092
7.460
0.261
58.50
4.810
<200
1.290
<200

96 hr
10.700
1.220
0.342
7.030

The cytotoxicity of 1 & 2 along with the free phen ligand and the
clinical antitumour agent cisplatin, were measured at 24 and 96hr
intervals using a standard MTT assay against three progressive
colorectal human-derived tumour cell lines (Table 3).† Both
complexes display remarkable cytotoxicity against all three lines.
Low-micromolar LD50 activities for both complexes were found
after 24 hrs of exposure and, significantly, these activities
reached the nano- and picomolar level after 96 hrs. As the
colorectal tumour lines progress (HT29→SW480→SW620)
activity of complex 1, over 96hrs, reduces from pico- to low
micomolar, while the activity of 2 remained consistently in the
low-mid nanomolar region. It is worth noting that while cisplatin
displays significant low-micromolar cytotoxicity against all
tumour lines after 96hrs, the activity of 1 & 2, in this period, is
superior to this agent by a factor between 1x101 – 1x105.
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Figure 6. Generation of endogenous reactive oxygen species (ROS)
within the cancer cell line HT29 after exposure to; (a) the free
ligand 1,10-phenanthroline, (b) the clinical antitumour agent
cisplatin, (c) complex 1 and (d) complex 2.

This journal is © The Royal Society of Chemistry [year]

Larvae of the insect Galleria mellonella were employed to assess
the in vivo cytotoxic tolerance of complexes 1 and 2, the ligand
phen and the clinical antitumour agent cisplatin. Larvae of G.
mellonella (the greater wax moth) have been widely used as a
convenient and inexpensive in vivo screening model to assess the
therapeutic potential of novel antimicrobial drugs.18, 19 They have
yielded results that are considered comparable to those obtained
using mammalian models.20 The innate defences of insects,
including G. mellonella, like those of mammals consist of
structural and passive barriers as well as humoral and cellular
responses within the haemolymph (analogous to the blood of
mammals).21 Indeed cellular responses within the haemolymph
are often activated by signal transduction systems comparable to
mice.22
Table 4. % Kill of G. mellonella larvae after exposures of 5000-100 µg/mL of
complexes 1 and 2, the ligand phen and the clinical antitumour drug cisplatin
†
over the period 72 hours Pauraic/Malachy we need to include ±SD

values in this table.

phen
1
2
cisplatin
70

Cellular Reactive Oxygen Species (ROS) Study
In order to elucidate the relationship between cytotoxicity and
ROS generation, complexes 1 & 2, along with phen and cisplatin,
were exposed to colorectal cancer cells, HT29, pre-treated with
the intracellular ROS indicator 2′,7′-dichlorofluorescin diacetate
(DCFH-DA).† In the presence of endogenously generated ROS,
DCFH-DA becomes oxidised to release the fluorophore 2′,7′dichlorofluorescin (DFC). Results are expressed relative to the
fluorescent response of the positive control (+Ctrl), hydrogen
peroxide, which is considered a potent generator of ROS.
Corrections were made using a negative control (-Ctrl), which
represents the natural level of cellular ROS generated. Results
were recorded at 15, 30, 60, 120 and 180 min intervals and are
shown in Figure 6. Complex 2 was found to be an exceptional
generator of ROS with greater activity relative to H2O2 (+Ctrl)
across the concentration range 1000-250 nM and approximate
equal activity to peroxide at 125 nM. It is worth commenting that
this species was almost seven times more active than the next
most effective ROS generator, phen. The activity of the
copper(II) complex (1) was somewhat lower than both free phen
and complex 2, indeed 1 needed to be assessed across a higher
concentration range (100,000-195 nM). The clinical agent
cisplatin was the least active of all tested compounds. This is
unsurprising considering it is non-catalytic, it has also been well
established that cisplatin only becomes cytotoxic upon its
hydrolysis to [Pt(NH3)2(OH)2], which generally occurs between
48-96 hrs.

In vivo Drug Tolerance
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% Kill of Galleria mellonella larve (72 hr)
Concentration µg/mL (mg/kg body weight)
5000 (333) 2000 (133) 1000 (67)
500 (33)
200 (13)
100
90
80
0
0
0
0
93.3
86.7
50
0
0
93.3
93.3
40
100
100
100
60
0

Testing was carried out in triplicate using ten healthy
G. mellonella larvae in the 6th developmental stage. Compounds
were tested across the concentration range 5000-100 µg/mL (33313 mg/kg average body weight) with sterile test solutions being
administered via hypodermic injection. Larvae were incubated at
30°C for 72 hr with survival being monitored at 24 hr intervals
and significance being determined using the log rank (MantelCox) method. Death was assessed by the lack of movement in
response to stimulus together with discolouration. Results are
presented (Table 4) as the mean % kill (± standard deviation)
resulting from exposure to tested compound. Galleria exposed to
high drug concentrations of 5000 and 2000 µg/mL showed poor
tolerance to all tested species. However, at lower concentration
ranges 1000-200 µg/mL significant differences were observed.
Tolerance of Galleria larvae exposed to complexes 1 and 2 was
highest of all tested species (50 and 40% kill at 67 mg/kg
respectively, and 0% kill at 33 mg/kg). The clinical antitumour
agent cisplatin was the poorest tolerated tested species with high
toxicity (60% kill) being observed at 500 µg/mL (33 mg/kg).
Encouragingly, the well-established rat LD50 of cisplatin (oral
exposure) is reported as 25.8 mg/kg body weight, thus, it appears
some agreement between these two models does exist.

Proposed DNA Self-Cleaving Mechanism
95

100

To conclude we would like to propose a mechanism by which of
complex 1 self-activates the phosphodiester backbone in DNA
via formation of a π carboxylate radical, concomitantly leading to
the reduced formation of [Cu(phen)2]+ (Figure 7). Aliphatic
carboxylate radicals are known to react by hydrogen abstraction
in close competition with decarboxylation.23, 24 Generation of a π
carboxylate radical within complex 1 would depend on the
strength of the HOMO d orbital overlap on Cu2+ with the oxygen
carboxylate. X-ray crystallography has revealed that the bond
length between Cu-O in 1 is 1.974Å and is significantly shorter
than the equivalent Mn-O bond in 2 which is 2.147 Å.13, 14
Journal Name, [year], [vol], 00–00 | 3

However, since the Cu-O bond length may be altered when 1
binds with DNA, it is impossible to know its exact length in vivo.
50

Scheme for Strategic Research progamme (CaBS). This work has
been carried out (in part) within the structures of the Focas
Research Institute, DIT, funded under The Irish National
Development Plan with assistance from the European Regional
Development Fund.
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Figure 7. Proposed mechanism of generating C-H bond activators (---)
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It is proposed the mechanism proceeds by the following
steps: (i) after the binding of 1 to DNA, homolytic cleavage at the
Cu-O
bond
generates
the
π
carboxyl
radical
(---) and the reduced d10 complex [Cu(phen)2]+, the resultant
carboxyl π radical undergoes rapid conversion to σ which
decarboxylates to generate CO2 and R• (---); (ii) [Cu(phen)2]+
reacts, as is known, with O2 to generate the superoxide radical
through an intermediate (---) yielding [Cu(phen)2]2+; (iii) complex
1 or [Cu(phen)2]2+ subsequently react with O2•- to generate H2O2
(as shown in Figure 5 & Table 2); (iv) since 1 does not
disproportionate hydrogen peroxide (shown in Table 2) a
subsequent reaction with H2O2 in (a) or O2 in (b) can generate
known metal-oxo (---) and hydroxyl radical (---) bond activators.
Since nuclease activity was detected in the presence of the
chelator EDTA (Figure 4 (c)) it would stand to reason that the
carboxylate radical or its breakdown product (R•) appears capable
of abstracting H• from the phosphodiester backbone in DNA. In
the absence of oxygen, the self-cleaving nuclease potential of 1 is
diminished (Figure 4 (c)), and since, in the proposed mechanism,
steps (ii)-(iv) are dependant on molecular oxygen, it also stands to
reason that the nuclease potential should be reduced in the
absence of these aerobically generated oxo- and hydroxo- bond
activators. Futher efforts are currently underway in our laboratory
to find further evidence for this proposed mechanism.

Conclusions
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In summary, dinuclear Cu2+ and Mn2+ bis-phen complexes of the
dicarboxylate, octanedioate, represent a significant advancement
compared to existing metal-phenanthroline adducts. Their
application
as
new
water-soluble
DNA-targeted
chemotherapeutics is highly significant given their powerful and
unprecedented cytotoxicity, encouraging in vivo drug tolerance
and unique modes of action. While both complexes are avid
binders of DNA, additionally, the copper(II) system has the
capacity to self-cleave DNA, possibly through the generation of a
π carboxyl radical, while the manganese(II) system is an
exceptional redox catalyst that generates unprecedented levels of
intracellular ROS within colon cancer cells.
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